kefzol 1 g sol. inj. (pdr.) i.m./i.v. flac.
eurocept international b.v. - céfazoline sodique - eq. céfazoline 1 g - poudre pour solution injectable - 1 g - céfazoline sodique - cefazolin
kefzol 1 g + lidocaine sol. inj. (pdr. + solv.) i.m. amp. + flac.
eurocept international b.v. - céfazoline sodique - eq. céfazoline 1 g - poudre et solvant pour solution injectable - céfazoline sodique - cefazolin; n01bb52 lidocaine, combinations
kefurox 1500 mg sol. inj./perf. (pdr.) i.m./i.v. flac.
eurocept b.v. - céfuroxime sodique 1500 mg - poudre pour suspension pour perfusion; poudre pour suspension injectable; poudre pour solution injectable/pour perfusion - cefuroxime
kefurox 750 mg sol. inj./perf. (pdr.) i.m./i.v. flac.
eurocept b.v. - céfuroxime sodique - eq. céfuroxime 750 mg - poudre pour solution injectable/pour perfusion - cefuroxime
thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - agents antinéoplasiques - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
ivermectin substipharm 3 mg comp.
substipharm - ivermectine 3 mg - comprimé - 3 mg - ivermectine 3 mg - ivermectin